The aberrant regulation of several PKC-mediated signal transduction pathways in ALS has been characterized so far, describing either impaired expression or altered activity of single PKC isozymes (α, β, ζ and δ). The gene discussed is PRRT2; the disease is amyotrophic lateral sclerosis.